• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可生物降解的阳离子脂质和可离子化阳离子脂质:更安全药用辅料的路线图。

Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients.

作者信息

Jörgensen Arne Matteo, Wibel Richard, Bernkop-Schnürch Andreas

机构信息

Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Center for Chemistry and Biomedicine, Innsbruck, 6020, Austria.

出版信息

Small. 2023 Apr;19(17):e2206968. doi: 10.1002/smll.202206968. Epub 2023 Jan 6.

DOI:10.1002/smll.202206968
PMID:36610004
Abstract

Cationic and ionizable cationic lipids are broadly applied as auxiliary agents, but their use is associated with adverse effects. If these excipients are rapidly degraded to endogenously occurring metabolites such as amino acids and fatty acids, their toxic potential can be minimized. So far, synthesized and evaluated biodegradable cationic and ionizable cationic lipids already showed promising results in terms of functionality and safety. Within this review, an overview about the different types of such biodegradable lipids, the available building blocks, their synthesis and cleavage by endogenous enzymes is provided. Moreover, the relationship between the structure of the lipids and their toxicity is described. Their application in drug delivery systems is critically discussed and placed in context with the lead compounds used in mRNA vaccines. Moreover, their use as preservatives is reviewed, guidance for their design is provided, and an outlook on future developments is given.

摘要

阳离子脂质和可离子化阳离子脂质被广泛用作辅助剂,但其使用会带来不良影响。如果这些辅料能迅速降解为内源性代谢产物,如氨基酸和脂肪酸,其潜在毒性可降至最低。到目前为止,已合成并评估的可生物降解阳离子脂质和可离子化阳离子脂质在功能和安全性方面已显示出有前景的结果。在本综述中,提供了关于此类可生物降解脂质的不同类型、可用构建单元、其合成以及被内源性酶裂解的概述。此外,还描述了脂质结构与其毒性之间的关系。对它们在药物递送系统中的应用进行了批判性讨论,并与mRNA疫苗中使用的先导化合物相关联。此外,对它们作为防腐剂的用途进行了综述,提供了其设计指导,并对未来发展进行了展望。

相似文献

1
Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients.可生物降解的阳离子脂质和可离子化阳离子脂质:更安全药用辅料的路线图。
Small. 2023 Apr;19(17):e2206968. doi: 10.1002/smll.202206968. Epub 2023 Jan 6.
2
Next-Generation Lipids in RNA Interference Therapeutics.新一代脂质在 RNA 干扰治疗中的应用。
ACS Nano. 2017 Aug 22;11(8):7572-7586. doi: 10.1021/acsnano.7b04734. Epub 2017 Jul 24.
3
Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out.为何mRNA-可电离脂质纳米颗粒制剂的寿命如此短暂:原因与解决办法。
Expert Opin Drug Deliv. 2023 Feb;20(2):175-187. doi: 10.1080/17425247.2023.2162876. Epub 2023 Jan 1.
4
Ionizable lipids based on branched fatty acids - An explorative study on Langmuir monolayers.基于支化脂肪酸的离子化脂质——Langmuir 单分子层的探索性研究。
Eur J Pharm Biopharm. 2024 Jul;200:114338. doi: 10.1016/j.ejpb.2024.114338. Epub 2024 May 23.
5
delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression.脂质纳米粒递送质粒 DNA:可离子化阳离子脂质对器官选择性基因表达的影响。
Biomater Sci. 2022 May 31;10(11):2940-2952. doi: 10.1039/d2bm00168c.
6
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.含可离子化阳离子脂质体和 siRNA 的脂质纳米粒的形成和形态。
ACS Nano. 2018 May 22;12(5):4787-4795. doi: 10.1021/acsnano.8b01516. Epub 2018 Apr 6.
7
pH-sensitive, tail-modified, ester-linked ionizable cationic lipids for gene delivery.pH 敏感的、尾部修饰的、酯键连接的可离子化阳离子脂质体用于基因递送。
Biomater Adv. 2022 Aug;139:212984. doi: 10.1016/j.bioadv.2022.212984. Epub 2022 Jun 14.
8
Facile scalable one-flow synthesis of ionizable cationic lipid library as precursors of nanoparticle carriers.易于规模化的单步合成可离子化阳离子脂质文库作为纳米载体前体。
Int J Pharm. 2024 Sep 5;662:124513. doi: 10.1016/j.ijpharm.2024.124513. Epub 2024 Jul 26.
9
Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.用于肌内 mRNA 递送的可离子化脂质的迭代设计。
J Am Chem Soc. 2023 Feb 1;145(4):2294-2304. doi: 10.1021/jacs.2c10670. Epub 2023 Jan 18.
10
Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.胆固醇缀合可离子化氨基脂质与生物膜的相互作用:脂质多态性、结构-活性关系,以及对 siRNA 递送的影响。
Langmuir. 2011 Aug 2;27(15):9473-83. doi: 10.1021/la201464k. Epub 2011 Jun 29.

引用本文的文献

1
Silencing RPL11 attenuates acute kidney injury by suppressing tubular apoptosis and macrophage-driven inflammation.沉默核糖体蛋白L11通过抑制肾小管细胞凋亡和巨噬细胞驱动的炎症反应减轻急性肾损伤。
Front Immunol. 2025 Aug 15;16:1642446. doi: 10.3389/fimmu.2025.1642446. eCollection 2025.
2
Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction.用于将小干扰RNA(siRNA)特异性递送至心肌梗死部位以促进心脏修复的自组装细胞外基质-脂质纳米颗粒复合物
Mater Today Bio. 2025 Aug 15;34:102205. doi: 10.1016/j.mtbio.2025.102205. eCollection 2025 Oct.
3
Biomaterials nanoplatform-based tumor vaccines for immunotherapy.
基于生物材料纳米平台的肿瘤免疫治疗疫苗
Bioact Mater. 2025 Jun 30;51:924-961. doi: 10.1016/j.bioactmat.2025.06.038. eCollection 2025 Sep.
4
The microbiome diversifies long- to short-chain fatty acid-derived N-acyl lipids.微生物群落使长链至短链脂肪酸衍生的N-酰基脂质多样化。
Cell. 2025 Jun 9. doi: 10.1016/j.cell.2025.05.015.
5
Therapeutic Application of mRNA for Genetic Diseases.信使核糖核酸在遗传性疾病中的治疗应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 May-Jun;17(3):e70019. doi: 10.1002/wnan.70019.
6
Structure-guided design of endosomolytic chloroquine-like lipid nanoparticles for mRNA delivery and genome editing.用于mRNA递送和基因组编辑的溶酶体裂解型氯喹样脂质纳米颗粒的结构导向设计
Nat Commun. 2025 May 7;16(1):4241. doi: 10.1038/s41467-025-59501-y.
7
Evaluation of Lipid-Based Transfection in Primary Monocytes Within an Ex Vivo Whole-Blood Model.在体外全血模型中对原代单核细胞进行基于脂质的转染评估。
Biomolecules. 2025 Mar 8;15(3):391. doi: 10.3390/biom15030391.
8
Advances and prospects of RNA delivery nanoplatforms for cancer therapy.用于癌症治疗的RNA递送纳米平台的进展与展望
Acta Pharm Sin B. 2025 Jan;15(1):52-96. doi: 10.1016/j.apsb.2024.09.009. Epub 2024 Sep 14.
9
Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.脂质介导的活性药物成分递送建模的计算方法
Mol Pharm. 2025 Mar 3;22(3):1110-1141. doi: 10.1021/acs.molpharmaceut.4c00744. Epub 2025 Jan 29.
10
Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment.用于癌症治疗中激活STING的环状二核苷酸的新型修饰和递送方式
Int J Nanomedicine. 2025 Jan 6;20:181-197. doi: 10.2147/IJN.S503780. eCollection 2025.